Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 11 September, 2019

Davidson Kempner Capital Manag

Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC

Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEYINFORMATION
Name of person dealing (Note 1) Davidson Kempner Capital Management LP
Company dealt in Allergan PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares
Dateofdealing 2019-09-10
  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
  LongShort
  Number   (%)Number   (%)
(1) Relevant securities 4,496,366 1.3716    
(2)Derivatives(otherthanoptions)        
(3) Options and agreements to purchase/sell        
Total 4,496,366 1.3716    
  1. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security:LongShort
  Number   (%)Number   (%)
(1) Relevant securities    
 

(2)Derivatives(otherthanoptions)
   
 

(3) Options and agreements to purchase/sell
   
Total    


Ap20

  1. DEALINGS (Note 4)
  1. Purchases and sales
 

Purchase/sale
 

Number of relevant securities
 

Price per unit (Note 5)
Purchase 5,000 162.0399 USD
Purchase 5,000 161.9740 USD
Purchase 5,000 161.8800 USD
Purchase 1,088 161.6313 USD
Purchase 5,000 162.2195 USD
Purchase 3,912 162.9779 USD
Purchase 28,235 163.7911 USD
  1. Derivatives transactions (other than options transactions)
Product name,

e.g.CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
       
  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasing or varying
Product name,
e.g.calloption
Writing,selling, purchasing, varying etc.Number of securities to which the option relates (Note 7) Exercise priceType,e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
             
  1. Exercising
Product name,

e.g.calloption
Number of securitiesExercise price per unit (Note 5)
     
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Natureoftransaction

(Note 8)
DetailsPriceperunit

(if applicable) (Note 5)
     


Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevantsecuritiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.

Is a Supplemental Form 8 attached? (Note 9)                                            YES/NO

Date of disclosure 2019-09-11
Contactname James Gange
Telephonenumber 212 446 4029
Ifa connected EFM, name of offeree/offeror with which connected  
Ifa connected EFM, state nature of connection (Note 10)  

a d v e r t i s e m e n t